Podcast: Download (Duration: 1:00 — 946.7KB)
Subscribe: RSS
ANCHOR LEAD: AN UNSUSPECTED TARGET MORPHS IN MANY BREAST CANCERS, ELIZABETH TRACEY REPORTS Many breast cancers are dependent on the hormone estrogen and have receptors for it, previously thought not to undergo much change as cancers progress. Now Ben Park, …
Podcast: Download (Duration: 1:06 — 1.0MB)
Subscribe: RSS
ANCHOR LEAD: HAS TOO MUCH RESTRICTION OF THE PHARMA/ACADEMIA RELATIONSHIP BEEN IMPOSED? ELIZABETH TRACEY REPORTS The FDA now regulates how pharmaceutical companies interact with academic institutions, with an eye toward preserving objectivity on the part of researchers. Ben Park, a …
Podcast: Download (Duration: 1:08 — 1.0MB)
Subscribe: RSS
ANCHOR LEAD: WILL INDUSTRY/ACADEMIC PARTNERSHIPS IMPERIL TRUST? ELIZABETH TRACEY REPORTS Industry often engages academic institutions, Johns Hopkins among them, to study their drugs, products or devices, and this is an important source of funding. Ben Park, a cancer researcher at …
Podcast: Download (Duration: 1:02 — 976.1KB)
Subscribe: RSS
ANCHOR LEAD: GROUPS LIKE STAND UP TO CANCER ARE VERY HELPFUL IN MOVING THE RESEARCH ENTERPRISE FORWARD, ELIZABETH TRACEY REPORTS What do major league baseball, the organization known as Stand Up to Cancer, and Johns Hopkins have in common? They’re …
Podcast: Download (Duration: 1:02 — 976.1KB)
Subscribe: RSS
ANCHOR LEAD: IN CONTRAST TO MANY INDUSTRY RELATIONSHIPS, JOHNS HOPKINS IS PLANNING A LONG TERM RELATIONSHIP WITH MEDIMMUNE, ELIZABETH TRACEY REPORTS Many relationships between academic institutions and industry are project-based, but not so a new endeavor between MedImmune, a biotech …
Podcast: Download (Duration: 1:04 — 1,013.3KB)
Subscribe: RSS
ANCHOR LEAD: WHAT DO JOHNS HOPKINS AND A BIOTECH FIRM HAVE IN COMMON? ELIZABETH TRACEY REPORTS Can Johns Hopkins and the biotechnology firm MedImmune craft a mutually beneficial relationship? That’s the hope of a new enterprise between Hopkins and this …
